The RSPCA has published the results of a survey which found that teachers in the UK are strongly in support of teaching animal welfare in the classroom, with 93% of respondents stating they would teach animal welfare in the classroom if they had the time.
95% also said that they believe that teaching children about animal welfare would help make them more compassionate and socially aware.
According to the survey of almost 800 teachers across England and Wales, 83% felt animal welfare should be part of the national curriculum. However, some had concerns about how it would be integrated into existing frameworks, and whether it would mean more demands on already overworked teachers.
RSPCA formal education manager Claire Morris said: "We felt it is easy to sit on the sidelines and state that animal welfare should be part of the curriculum, but it is far more practical and helpful to show that it can be done."
To address these concerns, the RSPCA says it created over 90 free lesson plans for teachers, which are linked to the English and Welsh Curricula. Many of the RSPCA's lesson plans overlap in subject areas including Science, Citizenship, Literacy and Numeracy, as well as provide springboards for assemblies and student councils.
Claire added: "We urge the government to consider integrating animal welfare into our children's education as a matter of urgency - as skills such as empathy, compassion and social consciousness have value as a child goes through the education system as well as when they enter adulthood and the world of work."
The RSPCA says this is particularly important because only 70% of respondents knew what the five animal welfare needs - which are central to the Animal Welfare Act - are.
As well as looking at the ethical side of animal welfare, 92% of teachers also expressed a strong preference for lessons specifically on animals' role in food and clothing production. It was felt that with young people better connected than ever before, they have an increasing awareness of social issues and expect higher ethical standards from companies.
International Cat Care has launched a competition in which veterinary practice staff are invited to take a 'selfie' of themselves with their favourite cat and upload it to the International Society of Feline Medicine (ISFM) Facebook page (www.facebook.com/ISFMcats), where cat lovers from around the world can vote for their favourite.
The Cattitude competition is designed to raising awareness of the charity's global Cat Friendly Clinic initiative.
The photograph that gets the most Facebook 'likes' will be used by the charity to help raise awareness of the Cat Friendly Clinic programme, which aims to promote the wellbeing of cats visiting or being hospitalised in a veterinary practice. Accredited Cat Friendly Clinics fulfil a set of broad criteria that show they recognise the specific needs of cats and their owners, and place cat welfare high in their practice priorities. Cat owners in turn are able to seek out clinics that have taken steps to help them overcome common barriers to clinic visits and reduce the stress of their pet.
The Cattitude competition runs from now until the 24th April. The winning staff member will receive £200 worth of John Lewis vouchers and the practice £400 worth of Thames Medical vouchers to be spent on feline-friendly equipment.
Practices may upload as many photos as they like to the Facebook page, and will be able to encourage clients to 'Like' their photos with campaign support materials which include downloadable in-clinic display posters, a series of supplied posts for their own Facebook page, written copy for their own clinic newsletter or email along with a proforma press release they can send to their local newspapers and publications.
Clinics can find more information on taking part in the Cattitude competition at www.facebook.com/ISFMcats orwww.icatcare.org/cattitude. Details of the ICC Cat Friendly Clinic initiative and accreditation can be found atwww.catfriendlyclinic.org along with a list of already-accredited vet clinics.
The association says the new Recognised Internships significantly enhance its existing programme which just listed available internships in equine practice.
Over the past year BEVA has worked with veterinary practices across the UK to develop a set of core skills that should be covered during an internship.
These standards sit alongside BEVA's existing Employment Toolkit which outlines what a new graduate should be considering when applying for a job (such as working hours, pay, CPD allowance).
Roger Smith, BEVA Junior Vice President said: “The new programme gives practices constructive guidance to provide a positive and inspirational introduction to a career as an equine vet, rather than the perhaps rushed and unintentionally unstructured, labour focused junior positions that have been experienced in times past.”
BEVA Chief Executive David Mountford said: “We are delighted that nearly 40 equine veterinary practices have already signed up to our Recognised Internships initiative.
"It is such a positive sign that as a profession we are all committed to ensuring we can offer the best start to those entering the profession.”
https://www.beva.org.uk/internships
Practices interested in joining the scheme should contact Fiona Cunnington - fiona@beva.org.uk
The Association says it has produced the leaflet after seeing an increasing number of dogs diagnosed with clinical or subclinical infection, along with reports of its zoonotic impact.
The document outlines the most important considerations concerning B. canis including transmission, diagnosis, management, public health implications and legislative requirements.
It takes into consideration information available from relevant Government Departments.
BSAVA says the document is by no means exhaustive but is intended to provide useful information and signpost to further resources.
www.bsavalibrary.com/brucella_canis
Photo: Walker16/Wikipedia. CC BY-SA 4.0.
A new survey by Petplan has given an insight into how veterinary nurses regard their job.
The survey, conducted at BVNA Congress, found that 73% of nurses feel that clients do not have a sufficient understanding of their role in practice.
Louisa Baker, the 2008 Petplan Vet Nurse of the Year, said: "Clients are often not aware of the skills required to be a vet nurse. Most clients believe we just handle the animals whereas we are often involved with surgical activities such as stitching and preparing drips."
Arguably, if pet owners under-appreciate the role of the nurse in practice, then they might also be expected to place a lower financial value on the care they provide. If that is the case, then it makes a lot of sense for vets and practice owners to find novel ways of communicating the breadth of work that nurses do, and its importance, to clients.
Other findings included 40% of nurses agreeing that direct contact with animals, such as caring for them through recovery, is the best part of the job. 54% told Petplan that they find the job extremely rewarding.
Nearly all nurses (99%) said that they value training and CPD to further their careers.
To support this desire to learn, Petplan has launched its Petplan Insurance Advisor training scheme. Already, over 500 nurses have completed one of the scheme's CPD qualifying modules.
The scheme enables the development of individual skills such as the ability to sell products and gain confidence with clients. Available online, vet nurses can participate in the scheme at work or at home. Visit http://www.petplanpia.co.uk/ for more information.
The university says it has implemented a range of health and safety measures to meet Government guidelines and allow for the controlled return of 150 first-year undergraduate students to its Sutton Bonington campus.
Since the latest cohort joined the university at the height of the UK lockdown, the school has delivered a programme of technology-assisted Fresher’s Week and teaching activities.
However, the return of the April cohort will enable face-to-face teaching that cannot be delivered remotely, specifically essential animal handling and health and safety skills required before students can embark on the work experience element of their course.
The practical sessions will form part of a blended approach to learning, with other lectures and tutorial support continuing to be delivered remotely to reduce the number of students in teaching buildings at any one time.
Dean of the School of Veterinary Medicine and Science Professor Gary England said: “We have missed being on campus with our students tremendously during the coronavirus lockdown and we are excited to be welcoming this cohort to Sutton Bonington in July.
“The health and safety of our students and staff has remained our top priority and has been at the heart of our planning process. Colleagues from across the university have been working intensively on the intricate detail required to ensure that adequate social distancing and hygiene measures are in place to allow this first step in a return to campus.”
Among the measures which have been introduced are:
The university says the return of its vet school cohort and the re-starting of face-to face-education at University of Nottingham Ningbo China at the end of April, where 5,000 students are now back on campus, will form the blueprint for the return of the majority of students to its UK campuses when the new academic term begins on 21 September.
Ceva Animal Health has added a new CPD module to its Cardio Academy website which focuses on common heart diseases in cats.
The 20 minute online seminar is hosted by Virginia Luis-Fuentes, Professor of Veterinary Cardiology at the Royal Veterinary College. After viewing the module, you can claim a CPD certificate by answering questions relating to the session.
Fraser Broadfoot MRCVS, product manager at Ceva, said: "Cardio Academy is going from strength to strength with over 1500 UK vets registered to the site which now includes 15 hours of free on-demand cardiology CPD with leading specialists."
For more information, visit: www.cardioacademy.cevalearn.com.
SRUC, which is the biggest provider of veterinary nursing, livestock husbandry and animal care training in Scotland, says it will offer a core veterinary programme to address existing shortages in veterinary provision, in areas such as rural veterinary practice, food production, food safety and animal and public health.
The College is first establishing a working group to progress the plans for the school. The group will be chaired by Professor Sir Pete Downes, former Principal and Vice-Chancellor of the University of Dundee.
Sir Pete will be joined by Sheila Voas, Chief Veterinary Officer for Scotland, former NFUS President Nigel Miller, SRUC Board member Jane Craigie, and Dr Kate Richards, who is a non-executive director on the SAC Commercial Board and currently the junior vice president of the RCVS, in line to become President in July.
Professor Caroline Argo, currently Dean of SRUC’s North Faculty, will lead the project for SRUC.
A report from BiGGAR Economics has found that the vet school could add £26 million GVA and 242 jobs to Scotland by 2030.
Professor Wayne Powell, Principal and Chief Executive of SRUC, said: “We are an ambitious institution with a bold vision for the future. This is a ground-breaking model to expand access to educational opportunities and broaden the range of potential students who would not ordinarily be able to attend a vet school. It will also help solve existing skills shortages across Scotland.
“We see a key role of the new vet school in sustaining primary agriculture and hence food and drink productivity, with the welfare of both livestock and companion animals at its heart. The school will produce champions for best-in-class animal welfare in support of these industries, which will help improve productivity, effectiveness, and sustainability.”
“Building on the excellent new facilities we have already announced for Aberdeen and Inverness, there is a lot of work still to be done, but we are ready to seize the opportunity.”
The poster gives information about things like lillies, chocolate, raisins, fertilisers, weedkillers and adders.
TVM will also be running its annual social media campaign about the most common spring dangers, giving practices digital content which they can share with clients.
To get a poster for your practice, contact your local TVM territory manager or visit https://www.tvm-uk.com/pet-dangers-order-free-display-materials-for-your-practice.
Maeve Cuffe, Junior Brand Manager of large animal products, at Forte Healthcare Ltd said: “As dairy herds increase in size, routine fertility visits result in larger numbers of cows requiring prostaglandin treatment.
"Also, some vets now recommend two shots of prostaglandin instead of one in certain synchronisation protocols.
"The 25 dose presentation of Genestran is a great addition to the range, helping vets keep enough prostaglandin in stock, while minimising waste.”
Genestran 50ml is available in all veterinary wholesalers now.
Technical questions about Genestran should be sent to: vets@fortehealthcare.com
Fort Dodge has announced that a challenge study has demonstrated the ability of Duvaxyn® IE-T Plus equine influenza vaccine to cross protect against A/equi-2/Sydney/07 (H3N8) two weeks after a two dose primary course. This strain was responsible for the financially devastating equine influenza outbreak in Australia in August 2007.
Duvaxyn IE-T Plus is an inactivated whole virus equine influenza vaccine, adjuvanted with an aqueous-based adjuvant. According to Fort Dodge, experts at a recent WHO meeting on human vaccines expressed the view that whole virus vaccines have the potential to induce a stronger and more broadly based response to circulating influenza strains than those contained in sub-unit vaccines because of the presence of the full set of virus proteins in the vaccine*.
The study, conducted by the Animal Health Trust, involved two groups of EIV seronegative horses. The first group, consisting of seven vaccinates, were given two dose of Duvaxyn IE-T Plus, 28 days apart, and challenged with A/equi-2/Sydney/07 (H3N8) virus strain 14 days after the second vaccination. The second group of unvaccinated horses was challenged at the same time. Duvaxyn IE-T Plus caused a statistically significant reduction in both clinical signs of the disease and in viral shedding.
Helen Barnes, EMEA Equine Business Manager for Fort Dodge, said: "The results of this challenge study provide reassurance for owners that horses vaccinated with Duvaxyn will be protected against circulating strains of equine influenza, including the Sydney strain which proved so damaging.
"As the benefits offered by whole virus technology are increasingly recognised, the popularity of vaccines based on this technology is re-emerging, particularly to combat a potential pandemic.
"The entire Duvaxyn range of equine vaccines, including the recently licensed Duvaxyn WNV for West Nile Virus, are based on the whole virus approach as we believe it offers a broad and consistent level of protection."
Newmarket-based Test and Treat was one of three finalists, for its U-Treat test which enables vets to diagnose a UTI and get antibiotic sensitivity results in an hour.
Rachel Kirkby MRCVS, Business Development Director at Test and Treat, said: "It’s a great accolade to be recognised by such a prestigious award. The Vet Record Innovation Award celebrates new innovations that can bring about improvement and make a real difference to vets in practice – and that’s exactly what we’re aiming to do with U-Treat.”
The second finalist was the Animal Welfare Assessment Grid, developed by Public Health England (PHE), in collaboration with the University of Surrey School of Veterinary Medicine. Initially developed in zoos, rescue and research centres, there are plans now to develop it for use in small animal practice and in the farm sector.
The overall winner was PBD Biotech for Actiphage, its test for bTB and Johne's disease which gives very early detection, thereby allowing vets and farmers to prevent the spread of infection.
For more information, visit: https://bvajournals.onlinelibrary.wiley.com/doi/10.1002/vetr.267
The study, titled The Veterinary Employment, Engagement and Retention Study (VEER), opened this week and aims to collect data from thousands of veterinary professionals across the United Kingdom and beyond.
Dr Dermot McInerney (pictured right), VetX Head of Research and Partnerships, said: “We will use the data collected to understand the factors influencing career happiness and how they impact on talent attraction and retention.
"We want to share this information with as many people as possible so we can work together to create a better, more sustainable situation for both employers and employees in veterinary practice.”
The study findings will be published later in 2022 and made available to all industry stakeholders.
All participants will receive a special report of the results with customised career advice, and be entered into a weekly draw to win a prize.
To take part in the survey, visit: www.vetxinternational.com/veer.
Preliminary results, which recorded a decline in the quantities of antimicrobials prescribed from 2014 to 2018, were published in 2022.
A further audit has now been undertaken in all 22 of the company's first opinion practices to investigate the age, breed and estimated weight of each horse, the clinical indication for antibiotic use, the drugs prescribed, their dose rates, the route of administration and whether culture and sensitivity were used to guide antimicrobial selection.
Data collection was completed in August 2022.
This secondary audit was conducted using a ‘point prevalence’ survey, in which each CVS Equine first opinion Quality Improvement Lead gathered information about all systemic antibiotics prescribed by each of their practices on one day a month for 12 consecutive months.
The project yielded information on 331 cases where systemic antimicrobials were prescribed.
Complete data about the first line-drug selection were available for 261 prescriptions.
The commonest prescribed antimicrobial was sulfadiazine/trimethoprim (41%), followed by oxytetracycline (23%), procaine penicillin (16%), doxycycline (13%), gentamicin (4%), metronidazole (1%), ceftiofur (1%) and enrofloxacin (1%).
Highest priority critically important antimicrobials (ceftiofur and enrofloxacin) were only prescribed in four horses (clinical indications for these included possible sepsis, skin infection, lower respiratory tract infection and a wound complication – in none of these cases was the first-line drug selection based on the results of culture and sensitivity.
Overall, the clinical indications for antimicrobial use were recorded in 246 cases; the commonest indications were cellulitis/lymphangitis (27%), uncomplicated wounds (19%), surgical prophylaxis (15%), respiratory infections (11%) and skin infections (8%).
Hattie Lawrence, Director of CVS Equine, said: “Though the impact of this work is yet to be documented, there is anecdotal evidence that it has raised awareness amongst our veterinarians of the importance of antimicrobial stewardship.
"Taken together, the results of both pieces of work will be used to help develop and inform clinical audits and clinical guidelines of antimicrobial use in horses.”
Reference
Tom graduated from the Royal Veterinary College (RVC) in 2017 and joined Synergy Farm Health full-time in 2018, after completing his postgraduate diploma (PGDipVCP) with the RVC.
Nominated by his practice, Tom is described as a fine example of a dedicated caring professional who is passionate about sustainability, has a keen sense of his clients’ needs, and has developed strong working relationships with the farms under his care.
The judging panel found that Tom uses data effectively in herd health planning to highlight areas of improvement, working in partnership with his clients to promote disease prevention and profitability.
Tom’s clients spoke of his knowledge and caring attitude and how much he is valued as part of their team.
Tom said: “It was a privilege to be a part of the awards and to see farmers and businesses acknowledged - farmers don’t always get the recognition they deserve and seeing British dairying showcased was amazing.
"I hope winning is reward for the time and effort colleagues at Synergy put into young vets too, and that I can put it to good use supporting clients and working with other organisations within the dairy industry.
"My aim as a vet has been simply to support clients the best I could, both clinically and emotionally, so to have won made it a fantastic night and one I won’t be forgetting!”
The runner up as Charlie Mays of LLM Vets, who the judging panel praised for making effective changes on farm towards preventive healthcare and using data to assist with health and profitability.
Charlie also lobbies government to support the interests of the farmer and the industry.
Sabrina Jordan from Virbac said: ‘Virbac has been supporting dairy vets with products and services for over 50 years and recognise the commitment of young dairy vets to the profession.
"The standard of nominations into this category was outstanding, and our winner and highly commended nominees are a true credit to the veterinary profession, both are shining lights of the future’.
Vita Referrals has been set up by Rob Quinn, an RCVS and EBVS Specialist in Small Animal Surgery, and Nick Blackburn and Stuart Cooke, both RCVS Advanced Practitioners in Small Animal Surgery.
They say that their aim is to ensure every pet owner has access to reasonably priced surgical care.
To that end, the clinic lists fixed costs for all of its major surgical specialities on its website, where it says clients should notice a significant reduction compared to other providers.
It also offers a 12-month post-surgical complications warranty.
Rob said: “Many pet-owners are unaware that there are three major companies which own the vast majority of veterinary practices in the UK.
"That is not necessarily of benefit to those using the services, as prices can rise when competition is low.
"Myself, Nick and Stuart felt very strongly that there was a different way to do things.
“No one becomes a vet to see animals suffer or pet-owners struggle to make tough financial decisions.
"We knew it was possible to offer a top quality service, with the best facilities and equipment available, whilst also keeping prices at a realistic level – and that is where the vision for Vita Referrals came from.
"We also wanted the freedom to offer collaborative decision-making, the removal of complex forms and bureaucracy and what we believe is an industry-leading 12-month complications guarantee on routine surgeries.
"It’s time there was more disruption and competition in the sector – and that will, ultimately, only be a good thing for pets, owners and vets.”
www.vitareferrals.co.uk
Ceva Animal Health has launched Marboxidin chewable tablets for dogs and cats for the treatment of micro-organisms susceptible to marbofloxacin, including skin and soft tissue infections (in cats and dogs), respiratory tract infections (in dogs and cats) and urinary tract infections (in dogs).
Containing marbofloxacin as its active ingredient, Marboxidin has a taste-masking lipid coating to ensure that its bitterness is not detected. In palatability trials over 90% of dogs and 80% of cats voluntarily consumed Marboxidin chewable tablets from the hand or in food1. Ceva says that Marboxidin is also very cost-effective, with an ongoing discount using the new CevaSave rebate scheme.
Marboxidin chewable tablets are available in three tablet sizes (5mg, 20mg and 80mg).
For further details, contact your Ceva Territory Manager or telephone the customer support team on (01494) 781510.
References
Given that vapocoolant is effective immediately, compared to EMLA cream which is recommended to be applied 60 minutes beforehand, the study suggests that in dogs at least, vapocoolant may be the better option in practice.
For the study, researchers from the Royal Veterinary College assessed 83 dogs and 18 cats requiring intravenous catheterisation for either blood donation collection or as oncology patients.
Patients were randomly assigned to receive either EMLA cream or a swab saturated with vapocoolant spray (Ethycalm / Invicta Animal Health) applied before catheterisation, and their reactions were assessed during initial restraint, limb handling, swab application and skin puncture.
Overall, there was no significant difference between vapocoolant spray and EMLA cream, and neither method appeared better at improving patient tolerance of intravenous catheter placement.
Vapocoolant spray was less effective than EMLA cream in reducing adverse reactions to skin puncture during catheterisation in cats, suggesting that EMLA may be preferable for feline patients.
Dogs that received vapocoolant spray showed a greater adverse response during swab application compared to those receiving EMLA, possibly due to the coldness of the swab.
Success of intravenous catheter placement was identical for both anaesthetics.
Dr Richie Trinder, lead author of the study, said: “The study is the first of its kind comparing vapocoolant spray and EMLA, and suggests in this context that the use of vapocoolant spray provides a similar degree of relief as EMLA, but with the added advantage of being instantaneous, instead of needing to wait the recommended 60 minutes for EMLA.”
Zoetis has announced that the European Commission has granted marketing authorization for Simparica™ (sarolaner) chewable tablets, a once-monthly medication for the treatment of fleas, ticks and sarcoptic mange in dogs beginning at eight weeks of age.
Dr. Balázs Capári, a Hungarian veterinary specialist in small animal medicine who participated in clinical trials of Simparica said: "The approval of Simparica gives veterinarians a new oral choice in parasite control for dogs. In my experience, Simparica has been shown to rapidly kill fleas and ticks with efficacy that persists for five weeks. Dog owners participating in the trials also reported that Simparica is very palatable; the chewable tablet was easily taken by their dogs. The convenience of a once monthly chewable tablet helps increase compliance with treatment, giving veterinarians and dog owners confidence in continuous protection."
Dr. Catherine Knupp, Executive Vice President and President, Research and Development at Zoetis, said: "At Zoetis, we focus our innovation on the most pressing needs of veterinarians, and that is what guided us to develop a new oral choice to provide dogs with persistent protection from fleas and ticks and treatment of mites that cause sarcoptic mange. Simparica is a result of the collaboration of Zoetis scientists worldwide, who share a determination to develop new medicines that deliver real value to our veterinary customers and the animals in their care. We are excited to bring this innovative medicine, Simparica, to veterinarians and dog owners across Europe."
The active substance of Simparica is sarolaner, a new ectoparasiticide in the isoxazoline class, developed by Zoetis.
Zoetis says the marketing authorization for Simparica was based on the results of field studies conducted in seven countries, involving more than 800 dogs of various breeds from at least eight weeks of age and 1.3 kg of weight. Simparica was shown to provide efficacy for at least five weeks against ticks and fleas. It demonstrated a rapid onset of action, killing fleas before they have a chance to lay eggs and can be used as part of a treatment strategy for the control of Flea Allergy Dermatitis. It proved effective in treating sarcoptic mange, a highly contagious skin disease in dogs.
In studies, Simparica killed all four species of tick dominant in Europe (Dermacentor reticulatus, Ixodes hexagonus, Ixodes ricinus and Rhipicephalus sanguineus) and species of flea that most frequently infect dogs in European countries (Ctenocephalides felis and Ctenocephalides canis). Simparica was well tolerated with no adverse events reported at the therapeutic dose.
Zoetis expects to launch Simparica in the EU in the first quarter of 2016. Simparica chewable tablets will be available in 5mg, 10mg, 20mg, 40mg and 80mg dosage strengths.
For more information about Simparica and full prescribing information, visit http://www.zoetis.com/products-services/companion-animals/dogs.
The VCMS, which is administered by Nockolds Solicitors, was formally launched by the RCVS as an alternative dispute resolution service in October 2017 following a year-long trial.
The aim of the service is to resolve, by mediation, disputes between clients and veterinary practices that do not meet the threshold of serious professional misconduct that is needed for the RCVS to investigate a concern through its formal processes.
Since the service’s trial, which started in October 2016, the VCMS has given preliminary mediation advice on how to resolve a case in more than 1,700 instances with over 580 cases having gone to full mediation of which 89% have concluded with a resolution.
Eleanor Ferguson, RCVS Registrar and Director of Legal Services, said: "From the perspective of both the public and the profession, the establishment of the VCMS has been a "win-win" situation. For the public it has provided them with an additional route to solve those complaints which wouldn’t cross the threshold to progress in the concerns investigation process.
"For the profession it has provided a more appropriate format for resolving a client dispute that doesn’t involve the time, effort and formal process of an RCVS investigation for those cases that will never amount to serious professional misconduct. I think this has been demonstrated by the fact that the vast majority of the profession are willing to engage with the VCMS process, even though it is entirely voluntary.
"The VCMS has also had a positive impact on the College and its concerns investigation process, allowing us to focus greater resources on those cases that do meet our threshold of serious professional misconduct. This has had a very clear impact on the speed with which we either close cases or move them on to the next stage of consideration by the Preliminary Investigation Committee (PIC), which, again, is important to both the public and the profession."
The College says that around 90% of cases investigated at Stage 1 of the process are now either closed or referred to PIC within four months – the College’s key performance indicator at this stage. This compares to around 50% of these cases being closed or referred within four months at Stage 1 in 2016.
The College also says that in total (including both preliminary and full mediation cases), 86% of the cases dealt with by VCMS were successfully mediated and feedback from both clients and veterinary practices has been largely positive. In client feedback from the third quarter of 2018, 93% said they would use the VCMS again and 79% considered it to be fair, while the equivalent figure amongst veterinary practices was 94% and 87% respectively.
Jennie Jones, a partner at Nockolds Solicitors who heads up the VCMS, said: "It is a good sign that mediation is largely working as it should when both parties are reporting similar satisfaction rates and we pride ourselves on negotiating resolutions that are acceptable and beneficial for both the clients and the practices.
"It is great to see that our efforts are also having an impact on the RCVS concerns investigation system by allowing it to concentrate on more serious cases."
More information about the RCVS concerns investigation process, including the different stages of an investigation, can be found at www.rcvs.org.uk/concerns
Further information about the VCMS can be found on its website at www.vetmediation.co.uk or by calling 0345 040 5834.
Merial has highlighted two new studies which the company says demonstrates the efficacy and safety of its canine NSAID, Previcox.
In the first study, Lecoindre and Pepin evaluated the beneficial effects of once daily administration of 5mg/kg Previcox to dogs suffering from osteoarthritis (OA) for 90 days. According to the company, response to treatment was excellent, with significant improvements observed in lameness scores, pain on manipulation of the affected joint and range of motion. Of particular note was the fact that the degree of improvement increased with duration of treatment, clearly demonstrating the benefits of longer term treatment. These results support the findings of a recent review of the safety and efficacy of long-term NSAID use in dogs with OA. The product's safety profile was also evaluated by means of biochemistry and haematology assessments. In addition, regular gastroscopic examinations were used to directly visualise the effect of treatment on the gastric mucosa. These safety assessments demonstrated that Previcox therapy was well tolerated, with no significant treatment related changes seen on biochemistry or gastroscopy, despite the fact that this was a geriatric population which included a number of dogs with a prior history of gastrointestinal tract disease.
Merials says the findings from a different study by Joubert, published in the South African Veterinary Journal, provide further confirmation of the beneficial effects of 90 days Previcox treatment in a geriatric population of dogs.
Commenting on the results of the two studies, Kevin Whelan, Merial's Veterinary Technical Manager said: "The outcome from these studies provide further evidence for the benefits of long term use of Previcox in dogs suffering from osteoarthritis. There is relatively little published information available on the use of NSAIDs in older dogs, and these results confirm that Previcox is well tolerated in this group of patients."
For further information about Previcox, please contact your local Territory Manager or call 0870 6000 123.
References:
The Smart Home Monitoring Kit for pets includes an indoor camera which comes with an in-built temperature sensor and night vision, a door sensor and a Smart Plug which can be remotely activated to turn on a radio, lamp, portable heater or fan to help keep animals content.
Although designed primarily for pet owners, Petplan says the kit is also being used by some veterinary practices to help provide additional security and monitoring capabilities within the practice.
The kit also contains an SD card allowing clients to share footage of their pet in the home with their veterinary surgeon when explaining behavioural symptoms. Likewise the practice will be able to record and share footage with their staff or clients.
Isabella Von Mesterhazy, Head of Marketing at Petplan, said: "For Petplan, keeping pets healthy always has been and always will be our priority. Spending time away from your pet can be hard, so the new pet Monitoring Kit addresses this problem by providing welcome peace of mind that they are safe and well. We are delighted to be able to offer Petplan veterinary practices and their staff the chance to get their hands on a Monitoring Kit at an exclusive price."
To find out more about the exclusive offer available for Petplan veterinary practices and staff until 9th December, visit petplanvet.co.uk.
Rodolfo said: “We are the only independent specialist veterinary hospital in the area with the equipment and experience to diagnose and manage neurological issues in pets.
"With a custom-built veterinary hospital and the expertise to help vets get the best results for their patients, we will provide the next level of affordable, specialist care for owners and their pets with the transparency that our independent status enables.
“We will work hand in hand with referring vets, consulting with them on the best approach for their clients and always keep them fully updated on progress as each case unfolds.
"Initially, we are offering neurology services, but we plan to quickly upscale our operations and offer other services like orthopaedics soon.”
Pets suffering from symptoms including seizures, pain, difficulty walking and problems with balance and orientation can be referred.
"Any peripheral nervous system problems and neuromuscular diseases outside the spinal cord area can also be identified and treated.
Rodolfo added: “My focus is on pure collaboration with the vets that refer to us and their owners.
"I’m wholeheartedly motivated by providing the very best service at accessible prices.
"With a focus on communication and compassion – we will always work with the first opinion vet to put the best interests of their clients’ pets first.
www.southeastvetreferrals.com
The British Safety Council has launched a new qualification to help people who drive as part of their work stay safe on the roads.
According to the organisation, the Level 2 Award in Safe Driving at Work provides work drivers with key knowledge of the hazards and risks associated with driving and equips them with valuable guidance on the measures available for reducing these risks, such as vehicle inspection, behaviour and defensive driving.
According to estimates from the Health and Safety Executive (HSE), up to a third of all road traffic accidents in Britain involve someone involved in work-related activity. In 2013, according to government figures, 1,713 people died on the road, with the total number of casualties standing at 183,670.
The Ofqual-regulated qualification, which is designed to be delivered by employers or training organisations, instructs learners on a range of topics including the particular risks associated with vulnerable road users, such as cyclists and pedestrians, the importance of regular vehicle safety checks and how to adapt driving style in response to changes in driving conditions or the actions of others.
Alex Botha, the British Safety Council's Chief Executive, said: "Driving can be a risky activity, a fact borne out by the high number of injuries and fatalities that occur annually on our roads.
"However, simple steps can be taken by employers and drivers to manage and reduce this risk. Our new Level 2 Award in Safe Driving at Work provides learners with all the essential knowledge to help them stay safe on the roads.
"Learners can expect to leave the qualification with a thorough knowledge of the main risks posed by driving - whether to themselves or other road users - and how to reduce them.
"Once registered with us, employers or training centres deliver the training using the high-quality teaching and student materials provided. Qualifications are assessed through a 45-minute multiple-choice examination that can be either taken online or on paper.
"This is a stand-alone qualification designed for delivery as a short course. It is also well-suited for integration into wider vocational programmes of study or, for example, as part of an induction programme. Students need no former knowledge or experience, so can come from a diverse range of educational and employment backgrounds.
"Safer driving habits should also feed through into workers' personal lives, providing employers with a valuable corporate social responsibility tool to help make our roads safer in and out of work."
Kit, who has served on Council as an elected member since 2013, is currently the Chair of the RCVS Finances & Resources Committee and has been RCVS Treasurer for the past three years.
He is also a member of a range of committees and project groups across the RCVS including: the Audit and Risk Committee; the PIC/ DC Liaison Committee; the Certification Subcommittee; the Estate Strategy Project Board; the RCVS Knowledge Board of Trustees; and the Advanced Practitioners Panel.
Since 2003 Kit has been working as an internist (he is an RCVS-recognised Specialist in Small Animal Medicine) in private referral practice. In 2006 he became a founding partner in a multidisciplinary referral centre that he saw grow from five to 65 members of staff within five years.
His interests include workforce issues, communicating the diverse clinical and non-clinical skills of veterinary surgeons to the general public and government, and facilitating life-long learning through achievable further professional qualifications and effective CPD.
Kit said: "It was a great honour to be elected as the next Junior Vice President by my fellow council members. I feel that I can make a positive contribution to the work that the RCVS is already undertaking in ensuring the veterinary team remains healthy and respected. In particular I am keen to look at how the RCVS can help find solutions to our workforce issues - improving retention as well as encouraging and facilitating vets and nurses back into the profession."
In addition to Kit being elected as JVP, the current holder of that office, Dr Mandisa Greene, was confirmed as President for 2020-21 and current President, Dr Niall Connell, was confirmed as Senior Vice-President for this period.
Professor Susan Dawson was voted in as RCVS Treasurer, and she will be formally invested in this role at Royal College Day on Friday, 10 July.
Professor David Argyle has been elected as Chair of Advancement of the Professions Committee for a second year, Dr Susan Paterson has been elected as Chair of Education Committee for her second year, and Dr Melissa Donald has been elected Chair of Standards Committee for her second year.
Kit and Melissa's positions are subject to their successful re-election in the 2020 RCVS Council Elections
More information on the RCVS Council and its members can be found on the RCVS website: https://www.rcvs.org.uk/who-we-are/rcvs-council.